Zhejiang Ausun Pharmaceutical Hits Day Low of CNY 8.05 Amid Price Pressure

Zhejiang Ausun Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 6.68% and reaching an intraday low of CNY 8.05. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Over the past week, Zhejiang Ausun has shown a slight increase of 0.12%, but its longer-term performance reveals a more concerning trend. The stock has decreased by 14.19% over the past year, significantly underperforming the China Shanghai Composite, which has gained 7.03% during the same period. Year-to-date, the stock is down 18.35%, while the market index has only declined by 5.16%. Financial metrics indicate challenges for the company, with net sales for the latest quarter falling by 16.2% to CNY 164.09 million and a net profit decline of 23.85% to CNY 88.54 million. The return on equity stands at 4.73%, and the price-to-book ratio is at 3.20, suggesting a high valuation relative to its equity. Overall, these indicators reflect a challenging environment for Zhejiang Ausun Pharmaceutical Co., Ltd. in the current market landscape.